Banu ALPASLAN MESCİ et al. 2017. Can Pentraxin-3 be a Candidate Marker in the Follow-Up of the Patients With Behçet’s Disease?. Archives of Rheumatology. 32, 2 (Jun. 2017), 091–095. DOI:https://doi.org/10.5606/ArchRheumatol.2017.6129.